Inflammatory myopathy is a term that defines a group of muscle diseases involving inflammation and degeneration of skeletal muscle tissues. They are thought to be autoimmune disorders. In inflammatory myopathies, inflammatory cells surround, invade, and destroy normal muscle fibers as though they were defective or foreign to the body. This eventually results in discernible muscle weakness. This muscle weakness is usually symmetrical and develops slowly over weeks to months or even years.
When using the term inflammatory myopathy, one is actually considering three separate disease entities, namely dermatomyositis (DM), polymyositis (PM), and inclusion body myositis (IBM). Although all of these diseases result in muscle weakness, each is unique in its development and treatment.
Inflammatory myopathies include a diverse group of disorders ranging from localized varieties confined to a single muscle or group of muscles, to diffuse forms in which there is widespread involvement of the skeletal muscles.
Inclusion body myositis (IBM) mainly affects individuals over the age of 50. The onset is truly insidious with symptoms often having been present for more than five years before diagnosis. Clinically and histologically, IBM may appear identical to another inflammatory myositis called polymyositis, although differences are clear in more than half the patients.
Weakness in (IBM) may be localized in the extremities, or asymmetric, and it may be accompanied by diminished deep-tendon reflexes. Disease progression is usually slow and steady in some, while it seems to plateau in others, leaving them with fixed weakness and atrophy (muscle wasting) of the involved musculature. In the muscle tissue, a characteristic change in IBM is the presence of intracellular rimmed vacuoles (pockets). The muscle fibers with pockets are now recognized to contain abnormal deposits of amyloid proteins.
Polymyositis usually occurs after the second decade of life and is a subacute myopathy (one that occurs over time) that evolves over weeks or months, and presents with weakness of the arm and leg muscles. PM mimics many other myopathies. It should be viewed as a syndrome of diverse causes that occurs separately or in association with other autoimmune disorders. In PM, muscle fibers are found to be in varying stages of necrosis (tissue death) and regeneration.
Dermatomyositis (DM) is identified by a characteristic skin rash accompanying or, more commonly, preceding muscle weakness. DM affects children and adults and presents a varying degree of muscle weakness that develops slowly, over weeks to months.
|
|
Author Info: Marcos do Carmo Oyama, Iuri Drumond Louro, The Gale Group Inc., Gale, Detroit, Gale Encyclopedia of Neurological Disorders, 2005 |